Skip to main navigation
Skip to search
Skip to main content
Universitat Autònoma de Barcelona Research Portal Home
Help & FAQ
Home
Profiles
Research units
Projects
Research output
Datasets
Student theses
Search by expertise, name or affiliation
Desarrollo de terapias génicas mínimamente invasivas para el tratamiento de la Mucopolisacaridos tipo IIIA, IIIB, IIIC y IIID y tipo II.
Bosch Tubert, Maria Fatima
(Principal Investigator)
Department of Biochemistry and Molecular Biology
Overview
Fingerprint
Research output
(1)
Project Details
Description
No disponible
Status
Finished
Effective start/end date
17/12/12
→
31/12/15
View all
View less
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
Hunter Syndrome
Medicine and Dentistry
100%
Mucopolysaccharidosis
Biochemistry, Genetics and Molecular Biology
75%
Iduronate 2 Sulfatase
Medicine and Dentistry
50%
Lysozyme
Biochemistry, Genetics and Molecular Biology
50%
Mouse
Biochemistry, Genetics and Molecular Biology
37%
Somatics
Medicine and Dentistry
25%
Therapeutic Procedure
Medicine and Dentistry
25%
Gene Therapy
Medicine and Dentistry
25%
Research output
Research output per year
2016
2016
2016
1
Article
Research output per year
Research output per year
CNS-directed gene therapy for the treatment of neurologic and somatic mucopolysaccharidosis type II (Hunter syndrome)
Motas, S.
,
Haurigot, V.
,
Garcia, M.
,
Marcó, S.
,
Ribera, A.
,
Roca, C.
,
Sánchez, X.
,
Sánchez, V.
,
Molas, M.
,
Bertolin, J.
,
Maggioni, L.
,
León, X.
,
Ruberte, J.
&
Bosch, F.
,
16 Jun 2016
,
In:
JCI insight.
1
,
9
,
19 p.
, e86696.
Research output
:
Contribution to journal
›
Article
›
Research
›
peer-review
Open Access
Hunter Syndrome
100%
Mucopolysaccharidosis
75%
Iduronate 2 Sulfatase
50%
Lysozyme
50%
Mouse
37%
48
Citations (Scopus)